Jim GreenwoodOvjeren akaunt

@JimGreenwood

President & CEO , Former Representative from Pennsylvania’s 8th District

Vrijeme pridruživanja: srpanj 2012.

Medijski sadržaj

  1. Yesterday, I attended a meeting of the CSIS Commission on Strengthening America’s Health Security. The Commission issued an important report in Nov '19 - “Ending the Cycle of Crisis and Complacency in the U.S. Global Health Security.”

  2. Deerfield’s Alex Karnal is absolutely right: adopting foreign price controls “prevents investors from being able to invest, and inventors from being able to invent.”

  3. In a must-watch video, Rachel King, co-founder and CEO of , urges President Trump to reject foreign price controls and ensure the U.S. continues to lead in innovation.

  4. New data from show people are paying more at the pharmacy due to rising deductibles - an insurance tactic that shifts greater costs onto patients. This is exactly why we need a holistic solution that reins in Rx costs for PATIENTS.

  5. I told that our industry can’t talk its way out of the pricing debate. continues to advocate for OOP caps on drug costs under Medicare Part D. Let’s put politics aside and help seniors better afford the medicines they need.

  6. During at , I discussed BIO's commitment to capping out-of-pocket costs for patients in Part D. The truth is, short-sighed policies currently in front of Congress will stifle innovation and do little to help seniors better afford the medicines they need.

  7. As an health care system, we must work together so no patient ever goes without needed medicine because of high out-of-pocket costs and so no policies are enacted that would disincentivize investment that could help patients still waiting for a cure.

  8. Honored to start my at the BayHelix Annual Meeting to discuss the importance of a stable U.S. regulatory environment to provide certainty to biotech investors so we can continue our progress on cross-border collaboration to cure disease.

  9. Happy 98th birthday to my beloved mother.

  10. So pleased that Virginia biochemist Camille Schrier, who grew up in my Newtown, PA neighborhood is the new Miss America showcasing biochemistry as her talent!

  11. Great interview with Jennifer Dent on efforts to ensure patients in have access to affordable and innovative treatments.

  12. is the wrong approach for lowering drug costs. Let’s move past this extreme, partisan bill and get to work on a bipartisan, holistic solution. Watch more of my reaction to today’s vote on ’s drug pricing plan.

  13. Welcomed business delegation from China's Hebei Province, including Vice Mayor of Hengshui City & Chairman of Hebei's Trade Promotion Council. We discussed the importance of pro-biotech policies to support the growth of the global biotech industry and cross-border opportunities.

  14. One of my favorite events of the year, speaking with BIO's amazing state-based partners. Thank you for all you do each and every day!

  15. Great to be down in Texas at the Capitol for the , I spoke about Congress and the national political scene.

  16. I outlined two moral imperatives at the BIO Patient Health and Advocacy Summit: ensure no patient goes without their medicine because of their out-of-pocket costs and ensure access isn’t expanded at the expense of innovation for patients still waiting for a cure.

  17. Earlier this week I recorded the pilot episode of our Good Day BIO podcast focused on the growing public health menace of antibiotic resistance. I'll send out the link next week. Glyn Edwards and are determined to conquer deadly superbugs. We must finance this work!

  18. Drug prices are NOT skyrocketing! As Congress debates ’s extreme Rx pricing plan that will stifle the development of innovative treatments, new data from is more proof.

  19. Earlier today, I announced to my team that we will begin the process of looking for a successor to lead this world-class organization, I announced that I will remain through 2020 and serve in an advisory capacity in 2021. Announcement here:

  20. Great conversation today with on the incredible bioscience in Massachusetts, and the treatments and cures member companies are developing every day.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·